UK’s NICE Rejects Novartis’ Xolair Again In Kids Aged 6 To 11 – Wall Street Journal


MSN News UK

UK's NICE Rejects Novartis' Xolair Again In Kids Aged 6 To 11
Wall Street Journal
or NICE, Thursday reiterated its earlier decision not to recommend Novartis AG's (NVS) asthma drug Xolair for children aged 6 to 11 years with severe,
Asthma rises as children return to schoolTelegraph.co.uk
September marks child asthma peakThe Press Association
Children with asthma 'at greater risk during September'MadeForMums
Visit Bulgaria –TopNews United Kingdom (blog) –Candis
all 24 news articles »

View full post on asthma – Google News

NICE rejects omalizumab for asthma in children – Healthcare Republic


News Fire

NICE rejects omalizumab for asthma in children
Healthcare Republic
Using omalizumab (Xolair) to treat children with persistent allergic asthma does not represent good value for NHS money, NICE has said.
Asthma drug decision 'nonsensical'The Press Association
Under-12s to be denied asthma jab… only if they live in EnglandDaily Mail
UK's NICE Rejects Novartis' Xolair Again In Kids Aged 6 To 11Wall Street Journal
Telegraph.co.uk –MadeForMums –Visit Bulgaria
all 26 news articles »

View full post on asthma – Google News